Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: Tumor versus striated muscle damage

被引:9
作者
Andrejevic-Blant, S
Woodtli, A
Wagnieres, G
Fontolliet, C
van den Bergh, H
Monnier, P
机构
[1] CHU Vaudois, Dept Otolaryngol Head & Neck Surg, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Pathol, CH-1011 Lausanne, Switzerland
[3] Swiss Fed Inst Technol, Inst Environm Engn, Lausanne, Switzerland
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1998年 / 42卷 / 02期
关键词
interstitial photodynamic therapy; photosensitizer; squamous cell carcinoma; striated muscle; light delivery; tissue damage; hamster;
D O I
10.1016/S0360-3016(98)00221-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The present study was initiated to determine the conditions under which a single photodynamic the conditions under which a treatment would induce maximal damage to a tumor with no or at least minimal reversible damage to a normal striated muscle. Methods and Materials: The technique of interstitial light delivery was used after prior 0.5 mg/kg tetra(m-hydroxyphenyl)chlorin administration in a hamster model. After having estimated the threshold light doses required for minimal muscle damage, the same light doses mere applied to squamous cell carcinomas to evaluate the efficiency of interstitial photodynamic therapy. Sixteen and 96 h after the injection, irradiation at 650 mn was performed on the thigh muscle of the left hind leg. The applied light doses ranged between 0.3-15 J and were delivered at an intensity of 44 mW per cm of diffuser length. Results: The threshold of muscle damage was obtained using light doses of 1.5-3 J at two drug-light intervals of 16 and 96 h, respectively. More than 85% of the tumor mass was destroyed when lesions were illuminated using these threshold conditions. In terms of immediate short-term tumor response, this means that for the given irradiation conditions, a relatively low threshold energy of only 1.5 or 3 J, depending on the drug-light interval, is sufficient to induce massive tumor destruction with minimal muscle damage. Conclusion: These results have implications for evaluating interstitial PDT for squamous cell cancers in unfavorable localization in the oral cavity or pharynx, such as at the base of the tongue. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 29 条
  • [1] Measurements by fluorescence microscopy of the time-dependent distribution of meso-tetra-hydroxyphenylchlorin in healthy tissues and chemically induced ''early'' squamous cell carcinoma of the Syrian hamster cheek pouch
    Andrejevic, S
    Savary, JF
    Monnier, P
    Fontolliet, C
    Braichotte, D
    Wagnieres, G
    vandenBergh, H
    [J]. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 1996, 36 (02) : 143 - 151
  • [2] 7,12-Dimethylbenz[a]anthracene-induced 'early' squamous cell carcinoma in the golden syrian hamster: Evaluation of an animal model and comparison with 'early' forms of human squamous cell carcinoma in the upper aero-digestive tract
    Andrejevic, S
    Savary, JF
    Fontolliet, C
    Monnier, P
    vandenBergh, H
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1996, 77 (01) : 7 - 14
  • [3] Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval
    AndrejevicBlant, S
    Hadjur, C
    Ballini, JP
    Wagnieres, G
    Fontolliet, C
    vandenBergh, H
    Monnier, P
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (08) : 1021 - 1028
  • [4] PHOTODYNAMIC THERAPY OF HEAD AND NECK CANCERS
    BIEL, MA
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1995, 11 (05): : 355 - 359
  • [5] Chang SC, 1996, INT J CANCER, V67, P555
  • [6] CUMMINGS CW, 1992, OTOLARYNGOLOGY HEAD
  • [7] EDELL ES, 1992, CHEST, V102, P131
  • [8] A PROSPECTIVE PHASE-II STUDY ON PHOTODYNAMIC THERAPY WITH PHOTOFRIN-II FOR CENTRALLY LOCATED EARLY-STAGE LUNG-CANCER
    FURUSE, K
    FUKUOKA, M
    KATO, H
    HORAI, T
    KUBOTA, K
    KODAMA, N
    KUSUNOKI, Y
    TAKIFUJI, N
    OKUNAKA, T
    KONAKA, C
    WADA, H
    HAYATA, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1852 - 1857
  • [9] Gluckman J L, 1995, Cancer Treat Res, V74, P159
  • [10] GLUCKMAN JL, 1983, LARYNGOSCOPE, V93, P71